$PLUS

RAIGUEL DARREN S sold $20K of PLUS (indirect holdings)

RAIGUEL DARREN S (CHIEF OPERATING OFFICER) sold 200 indirectly-held shares of EPLUS INC (PLUS) at $98.00 on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RAIGUEL DARREN S
Published Aug 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLUS
Neutral
high confidence
Mentioned
$PLUS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLUSNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price, and that it was executed under a 10b5-1 plan. This typically does not change valuation expectations absent other company-specific news.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no fundamental catalyst in the text.

03

What to watch

The filing specifies indirect holdings and a pre-arranged plan; without additional context (e.g., total insider selling trend), the signal is weak.

Relevance 2/10Novelty 3/10Timing: SEC Form 4 filed Aug 6, covering a sale dated Aug 4.

Background

The article is an SEC Form 4 insider transaction disclosure for EPLUS Inc (PLUS) by COO Darren S Raiguel, reported as an indirect holding sale.

Company-level read

Ticker impact

$PLUSNeutralHigh confidence
Context

EPLUS COO Darren S Raiguel sold 200 shares of PLUS at $98/share under a 10b5-1 plan, filing disclosed Aug 6.

Expected impact

Likely minimal near-term impact; any effect is more about signaling than fundamentals.

Evidence & confidence

Form 4 shows an open-market sale of small size relative to typical company float, explicitly under a pre-arranged 10b5-1 plan, with no accompanying guidance, deal, or regulatory action.

Market effects

No clear sector read-through; insider sales under 10b5-1 are generally not sector-moving.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with private information, so traders may still watch for follow-on filings or unusual volume.

Key entities

  • PLUS

    EPLUS Inc, subject of the Form 4 insider transaction disclosure.

  • RAIGUEL DARREN S

    Chief Operating Officer of EPLUS Inc, reported open-market sale of shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDWMedAI 8/10

Q2 Earnings Outperformers: CDW (NASDAQ:CDW) And The Rest Of The IT Distribution & Solutions Stocks

CDW, ePlus, TD SYNNEX, and ScanSource reported Q2 earnings. CDW (-6%) and ePlus (-10.5%) saw stock declines, while ScanSource (+5.5%) rose. TD SYNNEX (-10.5%) reported strong revenue growth but also fell. ePlus reported flat revenue but beat EPS estimates. ScanSource had the largest analyst estimate beat. TD SYNNEX reported $19.57B revenue, up 31% YoY, and beat EPS estimates and guidance.

$PLUSMed

Plus500 increases buybacks as US growth continues

Plus500 said it will increase shareholder returns via buybacks alongside its half-year results. The company reported double-digit revenue growth year over year and Ebitda up 1% to $188mn. It attributed a lower Ebitda margin (45% to 41%) to higher marketing spend to attract new customers, while expanding in US futures.

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.